Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	amino acid sensor activity	SAR1B SAR1A	1.67e-05	2	82	2	GO:0140785
GeneOntologyMolecularFunction	ryanodine-sensitive calcium-release channel activity	RYR2 RYR3	9.94e-05	4	82	2	GO:0005219
GeneOntologyMolecularFunction	calcium-induced calcium release activity	RYR2 RYR3	2.47e-04	6	82	2	GO:0048763
GeneOntologyMolecularFunction	extracellularly glycine-gated ion channel activity	GLRB GLRA3	2.47e-04	6	82	2	GO:0016933
GeneOntologyMolecularFunction	extracellularly glycine-gated chloride channel activity	GLRB GLRA3	2.47e-04	6	82	2	GO:0016934
GeneOntologyMolecularFunction	ferrous iron binding	ALKBH1 UROD HEPH	2.50e-04	30	82	3	GO:0008198
GeneOntologyMolecularFunction	inhibitory extracellular ligand-gated monoatomic ion channel activity	GLRB GLRA3	4.59e-04	8	82	2	GO:0005237
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity	MTMR6 MTM1	8.94e-04	11	82	2	GO:0052629
GeneOntologyMolecularFunction	histone H4K12 acetyltransferase activity	MEAF6 KAT2A	1.07e-03	12	82	2	GO:0043997
GeneOntologyMolecularFunction	molecular sensor activity	SAR1B NOX4 SAR1A	1.14e-03	50	82	3	GO:0140299
GeneOntologyMolecularFunction	phosphatidylinositol-3-phosphate phosphatase activity	MTMR6 MTM1	1.47e-03	14	82	2	GO:0004438
GeneOntologyMolecularFunction	glycine binding	GLRB GLRA3	1.47e-03	14	82	2	GO:0016594
GeneOntologyMolecularFunction	phosphatidylinositol monophosphate phosphatase activity	MTMR6 MTM1	1.69e-03	15	82	2	GO:0052744
GeneOntologyMolecularFunction	histone H3 acetyltransferase activity	MEAF6 KAT2A	1.69e-03	15	82	2	GO:0010484
GeneOntologyMolecularFunction	lyase activity	ALKBH1 POLG UROD CA10 ADCY5	1.81e-03	212	82	5	GO:0016829
GeneOntologyMolecularFunction	phosphatidylinositol-3,5-bisphosphate phosphatase activity	MTMR6 MTM1	1.93e-03	16	82	2	GO:0106018
GeneOntologyCellularComponent	glycine-gated chloride channel complex	GLRB GLRA3	1.60e-05	2	84	2	GO:0016935
GeneOntologyCellularComponent	sarcoplasmic reticulum	AGL NOX4 SAR1A RYR2 RYR3	2.80e-05	88	84	5	GO:0016529
GeneOntologyCellularComponent	sarcoplasm	AGL NOX4 SAR1A RYR2 RYR3	9.67e-05	114	84	5	GO:0016528
GeneOntologyCellularComponent	calcium channel complex	CACNA2D2 CATSPERG RYR2 RYR3	2.14e-04	73	84	4	GO:0034704
Domain	Small_GTPase_SAR1	SAR1B SAR1A	2.00e-05	2	84	2	IPR006687
Domain	SAR1	SAR1B SAR1A	2.00e-05	2	84	2	PS51422
Domain	Ryanrecept_TM4-6	RYR2 RYR3	5.98e-05	3	84	2	IPR009460
Domain	RyR	RYR2 RYR3	5.98e-05	3	84	2	PF02026
Domain	Ryanodine_rcpt	RYR2 RYR3	5.98e-05	3	84	2	IPR003032
Domain	RR_TM4-6	RYR2 RYR3	5.98e-05	3	84	2	PF06459
Domain	Ryan_recept	RYR2 RYR3	5.98e-05	3	84	2	IPR013333
Domain	RIH_assoc	RYR2 RYR3	2.96e-04	6	84	2	PF08454
Domain	RIH_assoc-dom	RYR2 RYR3	2.96e-04	6	84	2	IPR013662
Domain	RIH_dom	RYR2 RYR3	2.96e-04	6	84	2	IPR000699
Domain	Ins145_P3_rcpt	RYR2 RYR3	2.96e-04	6	84	2	IPR014821
Domain	Ryanodine_recept-rel	RYR2 RYR3	2.96e-04	6	84	2	IPR015925
Domain	EPTP	LGI3 LGI1	2.96e-04	6	84	2	PF03736
Domain	-	RYR2 RYR3	2.96e-04	6	84	2	1.25.10.30
Domain	EPTP	LGI3 LGI1	2.96e-04	6	84	2	IPR005492
Domain	RYDR_ITPR	RYR2 RYR3	2.96e-04	6	84	2	PF01365
Domain	Ins145_P3_rec	RYR2 RYR3	2.96e-04	6	84	2	PF08709
Domain	LRRCT	LGI3 TLR5 LGI1	3.96e-04	32	84	3	PF01463
Domain	EAR	LGI3 LGI1	4.14e-04	7	84	2	IPR009039
Domain	EAR	LGI3 LGI1	4.14e-04	7	84	2	PS50912
Domain	MIR	RYR2 RYR3	8.79e-04	10	84	2	PS50919
Domain	MIR	RYR2 RYR3	8.79e-04	10	84	2	PF02815
Domain	MIR	RYR2 RYR3	8.79e-04	10	84	2	SM00472
Domain	MIR_motif	RYR2 RYR3	8.79e-04	10	84	2	IPR016093
Domain	Rap_GAP	GARNL3 SIPA1L1	8.79e-04	10	84	2	PF02145
Domain	Rap_GAP_dom	GARNL3 SIPA1L1	1.07e-03	11	84	2	IPR000331
Domain	RAPGAP	GARNL3 SIPA1L1	1.07e-03	11	84	2	PS50085
Domain	Glycoside_hydrolase_SF	GLB1L AGL MANEA	1.75e-03	53	84	3	IPR017853
Domain	Myotubularin-like_Pase_dom	MTMR6 MTM1	1.76e-03	14	84	2	IPR010569
Domain	PPASE_MYOTUBULARIN	MTMR6 MTM1	1.76e-03	14	84	2	PS51339
Domain	Myotubularin_fam	MTMR6 MTM1	1.76e-03	14	84	2	IPR030564
Domain	Myotub-related	MTMR6 MTM1	1.76e-03	14	84	2	PF06602
Domain	-	MTMR6 RASA2 MTM1 ARHGAP12 PLEKHA5 PREX2 PLCE1	1.90e-03	391	84	7	2.30.29.30
Domain	Gal_mutarotase_SF_dom	LGI3 LGI1	2.60e-03	17	84	2	IPR011013
Domain	PH_dom-like	MTMR6 RASA2 MTM1 ARHGAP12 PLEKHA5 PREX2 PLCE1	3.06e-03	426	84	7	IPR011993
Domain	Tyr_Pase_AS	MTMR6 MTM1 DUSP11	4.35e-03	73	84	3	IPR016130
Domain	RASGEF	RASGRP2 PLCE1	6.06e-03	26	84	2	PS00720
Domain	TYR_PHOSPHATASE_1	MTMR6 MTM1 DUSP11	6.87e-03	86	84	3	PS00383
Domain	TYR_PHOSPHATASE_2	MTMR6 MTM1 DUSP11	7.09e-03	87	84	3	PS50056
Domain	TYR_PHOSPHATASE_dom	MTMR6 MTM1 DUSP11	7.09e-03	87	84	3	IPR000387
Pubmed	Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease.	RYR2 RYR3	5.90e-06	2	85	2	21531043
Pubmed	Genetic variation of the human glycine receptor subunit genes GLRA3 and GLRB and susceptibility to idiopathic generalized epilepsies.	GLRB GLRA3	5.90e-06	2	85	2	11496371
Pubmed	Modulation of calcium signalling by dominant negative splice variant of ryanodine receptor subtype 3 in native smooth muscle cells.	RYR2 RYR3	5.90e-06	2	85	2	16678258
Pubmed	Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases.	MTMR6 MTM1	5.90e-06	2	85	2	12646134
Pubmed	Functional overlap between the mammalian Sar1a and Sar1b paralogs in vivo.	SAR1B SAR1A	5.90e-06	2	85	2	38687799
Pubmed	Tissue-specific alternative splicing of mouse brain type ryanodine receptor/calcium release channel mRNA.	RYR2 RYR3	5.90e-06	2	85	2	8898078
Pubmed	The mouse sino-atrial node expresses both the type 2 and type 3 Ca(2+) release channels/ryanodine receptors.	RYR2 RYR3	5.90e-06	2	85	2	14550562
Pubmed	Silencing of mammalian Sar1 isoforms reveals COPII-independent protein sorting and transport.	SAR1B SAR1A	5.90e-06	2	85	2	23433038
Pubmed	The endoplasmic reticulum coat protein II transport machinery coordinates cellular lipid secretion and cholesterol biosynthesis.	SAR1B SAR1A	5.90e-06	2	85	2	24338480
Pubmed	Modulation of membrane rigidity by the human vesicle trafficking proteins Sar1A and Sar1B.	SAR1B SAR1A	5.90e-06	2	85	2	22974979
Pubmed	Decreased expression of ryanodine receptors alters calcium-induced calcium release mechanism in mdx duodenal myocytes.	RYR2 RYR3	5.90e-06	2	85	2	14985349
Pubmed	Molecular analysis of SAR1-related cDNAs from a mouse pituitary cell line.	SAR1B SAR1A	5.90e-06	2	85	2	8262187
Pubmed	SAR1B senses leucine levels to regulate mTORC1 signalling.	SAR1B SAR1A	5.90e-06	2	85	2	34290409
Pubmed	Type 1 and type 3 ryanodine receptors are selectively involved in muscarinic antinociception in mice: an antisense study.	RYR2 RYR3	1.77e-05	3	85	2	18403125
Pubmed	Heterogeneous gene expression and functional activity of ryanodine receptors in resistance and conduit pulmonary as well as mesenteric artery smooth muscle cells.	RYR2 RYR3	1.77e-05	3	85	2	18434746
Pubmed	Small GTPases SAR1A and SAR1B regulate the trafficking of the cardiac sodium channel Nav1.5.	SAR1B SAR1A	1.77e-05	3	85	2	30251687
Pubmed	Control of Neuronal Ryanodine Receptor-Mediated Calcium Signaling by Calsenilin.	RYR2 RYR3	1.77e-05	3	85	2	29730765
Pubmed	SPRY domains in ryanodine receptors (Ca(2+)-release channels).	RYR2 RYR3	1.77e-05	3	85	2	9204703
Pubmed	The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues.	RYR2 RYR3	1.77e-05	3	85	2	7876312
Pubmed	Ryanodine receptors are expressed in epidermal keratinocytes and associated with keratinocyte differentiation and epidermal permeability barrier homeostasis.	RYR2 RYR3	1.77e-05	3	85	2	21881589
Pubmed	Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors).	RYR2 RYR3	1.77e-05	3	85	2	12213830
Pubmed	Expression of the ryanodine receptor type 3 calcium release channel during development and differentiation of mammalian skeletal muscle cells.	RYR2 RYR3	1.77e-05	3	85	2	9242641
Pubmed	Bidirectional coupling between ryanodine receptors and Ca2+ release-activated Ca2+ (CRAC) channel machinery sustains store-operated Ca2+ entry in human T lymphocytes.	RYR2 RYR3	1.77e-05	3	85	2	22948152
Pubmed	Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain.	RYR2 RYR3	1.77e-05	3	85	2	10788707
Pubmed	RYR2 proteins contribute to the formation of Ca(2+) sparks in smooth muscle.	RYR2 RYR3	1.77e-05	3	85	2	15024040
Pubmed	Calcineurin upregulates local Ca(2+) signaling through ryanodine receptor-1 in airway smooth muscle cells.	RYR2 RYR3	1.77e-05	3	85	2	25239916
Pubmed	Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor.	RYR2 RYR3	1.77e-05	3	85	2	7621815
Pubmed	A gene-specific cerebral types 1, 2, and 3 RyR protein knockdown induces an antidepressant-like effect in mice.	RYR2 RYR3	1.77e-05	3	85	2	18643873
Pubmed	Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2).	RYR2 RYR3	1.77e-05	3	85	2	11159936
Pubmed	Nonsense in the testis: multiple roles for nonsense-mediated decay revealed in male reproduction.	PLEKHA5 TDRD6	1.77e-05	3	85	2	28444146
Pubmed	Small sequence variations between two mammalian paralogs of the small GTPase SAR1 underlie functional differences in coat protein complex II assembly.	SAR1B SAR1A	1.77e-05	3	85	2	32358066
Pubmed	Mitochondrial respiratory chain disorders in the Old Order Amish population.	NDUFAF2 POLG	1.77e-05	3	85	2	27344355
Pubmed	Molecular identification of the ryanodine receptor pore-forming segment.	RYR2 RYR3	1.77e-05	3	85	2	10473538
Pubmed	Chromosomal localization of murine ryanodine receptor genes RYR1, RYR2, and RYR3 by in situ hybridization.	RYR2 RYR3	1.77e-05	3	85	2	7959768
Pubmed	The organization of proteins in the human red blood cell membrane. A review.	RYR2 RYR3	1.77e-05	3	85	2	4600883
Pubmed	Regulation of mouse egg activation: presence of ryanodine receptors and effects of microinjected ryanodine and cyclic ADP ribose on uninseminated and inseminated eggs.	RYR2 RYR3	1.77e-05	3	85	2	7635066
Pubmed	Splice-specific roles of glycine receptor alpha3 in the hippocampus.	GLRB GLRA3	1.77e-05	3	85	2	19723286
Pubmed	The FYVE domain of Smad Anchor for Receptor Activation (SARA) is required to prevent skin carcinogenesis, but not in mouse development.	SAR1B SAR1A	3.53e-05	4	85	2	25170969
Pubmed	A glutathione deficit alters dopamine modulation of L-type calcium channels via D2 and ryanodine receptors in neurons.	RYR2 RYR3	3.53e-05	4	85	2	18206662
Pubmed	Expression and mRNA splicing of glycine receptor subunits and gephyrin during neuronal differentiation of P19 cells in vitro, studied by RT-PCR and immunocytochemistry.	GLRB GLRA3	3.53e-05	4	85	2	9051263
Pubmed	Activation of glycine receptor phase-shifts the circadian rhythm in neuronal activity in the mouse suprachiasmatic nucleus.	GLRB GLRA3	3.53e-05	4	85	2	21486797
Pubmed	Ryanodine receptor calcium release channels: lessons from structure-function studies.	RYR2 RYR3	3.53e-05	4	85	2	23413940
Pubmed	Requirement for the ryanodine receptor type 3 for efficient contraction in neonatal skeletal muscles.	RYR2 RYR3	3.53e-05	4	85	2	9384575
Pubmed	Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP.	MTMR6 MTM1	3.53e-05	4	85	2	12847286
Pubmed	Regional distribution of the leucine-rich glioma inactivated (LGI) gene family transcripts in the adult mouse brain.	LGI3 LGI1	3.53e-05	4	85	2	19833108
Pubmed	Alpha subunit-dependent glycine receptor clustering and regulation of synaptic receptor numbers.	GLRB GLRA3	3.53e-05	4	85	2	28883437
Pubmed	Partial cloning and differential expression of ryanodine receptor/calcium-release channel genes in human tissues including the hippocampus and cerebellum.	RYR2 RYR3	3.53e-05	4	85	2	9607712
Pubmed	Conserved and divergent functions of Nfix in skeletal muscle development during vertebrate evolution.	RYR2 RYR3	3.53e-05	4	85	2	23482488
Pubmed	NOVA-dependent regulation of cryptic NMD exons controls synaptic protein levels after seizure.	GLRB PLEKHA5 RASGRP2	3.95e-05	27	85	3	23359859
Pubmed	Sorcin is an early marker of neurodegeneration, Ca2+ dysregulation and endoplasmic reticulum stress associated to neurodegenerative diseases.	RYR2 RYR3	5.87e-05	5	85	2	33060591
Pubmed	The flagellin-TLR5-Nox4 axis promotes the migration of smooth muscle cells in atherosclerosis.	TLR5 NOX4	5.87e-05	5	85	2	31292433
Pubmed	Developmental regulation of glycine receptors at efferent synapses of the murine cochlea.	GLRB GLRA3	5.87e-05	5	85	2	21850450
Pubmed	Presenilins regulate calcium homeostasis and presynaptic function via ryanodine receptors in hippocampal neurons.	RYR2 RYR3	5.87e-05	5	85	2	23918386
Pubmed	Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester.	RASGRP2 PLCE1	5.87e-05	5	85	2	18172297
Pubmed	Oligodendrocyte-derived LGI3 and its receptor ADAM23 organize juxtaparanodal Kv1 channel clustering for short-term synaptic plasticity.	LGI3 LGI1	5.87e-05	5	85	2	38194969
Pubmed	Native glycine receptor subtypes and their physiological roles.	GLRB GLRA3	5.87e-05	5	85	2	18721822
Pubmed	Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells.	RYR2 RYR3	5.87e-05	5	85	2	19011160
Pubmed	Membrane depolarization causes a direct activation of G protein-coupled receptors leading to local Ca2+ release in smooth muscle.	RYR2 RYR3	8.80e-05	6	85	2	19549818
Pubmed	Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos.	RYR2 RYR3	8.80e-05	6	85	2	26025922
Pubmed	Roles of I(f) and intracellular Ca2+ release in spontaneous activity of ventricular cardiomyocytes during murine embryonic development.	RYR2 RYR3	8.80e-05	6	85	2	23463619
Pubmed	Phospholipase Cε hydrolyzes perinuclear phosphatidylinositol 4-phosphate to regulate cardiac hypertrophy.	RYR2 PLCE1	8.80e-05	6	85	2	23540699
Pubmed	A common protein interaction domain links two recently identified epilepsy genes.	LGI3 LGI1	8.80e-05	6	85	2	12095917
Pubmed	FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells.	RYR2 RYR3	8.80e-05	6	85	2	14592808
Pubmed	A calcium-induced calcium release mechanism supports luteinizing hormone-induced testosterone secretion in mouse Leydig cells.	RYR2 RYR3	8.80e-05	6	85	2	20519450
Pubmed	Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging.	RYR2 RYR3	8.80e-05	6	85	2	25966694
Pubmed	HIV-1 Tat activates neuronal ryanodine receptors with rapid induction of the unfolded protein response and mitochondrial hyperpolarization.	RYR2 RYR3	8.80e-05	6	85	2	19009018
Pubmed	The novel EPTP repeat defines a superfamily of proteins implicated in epileptic disorders.	LGI3 LGI1	8.80e-05	6	85	2	12217514
Pubmed	Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders.	SAR1B SAR1A	8.80e-05	6	85	2	12692552
Pubmed	IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1.	RYR2 RYR3	8.80e-05	6	85	2	16844763
Pubmed	The claw paw mutation reveals a role for Lgi4 in peripheral nerve development.	LGI3 LGI1	1.23e-04	7	85	2	16341215
Pubmed	Developmental expression of the calcium release channels during early neurogenesis of the mouse cerebral cortex.	RYR2 RYR3	1.23e-04	7	85	2	11860456
Pubmed	Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.	RYR2 RYR3	1.23e-04	7	85	2	20962236
Pubmed	Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death.	RYR2 RYR3	1.64e-04	8	85	2	19033399
Pubmed	Sequential docking, molecular differentiation, and positioning of T-Tubule/SR junctions in developing mouse skeletal muscle.	RYR2 RYR3	1.64e-04	8	85	2	11784029
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	H1-10 ATP6V1H TENT4B CACNA2D2 DYNC2H1 MARS1 CSNK2A2 NOL6 NIPSNAP1 WDR46 TDRD6 SAR1A	1.77e-04	1425	85	12	30948266
Pubmed	Characterization of the myotubularin dual specificity phosphatase gene family from yeast to human.	MTMR6 MTM1	2.62e-04	10	85	2	9736772
Pubmed	AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.	MTM1 RYR2	2.62e-04	10	85	2	18434328
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	MEAF6 NDUFAF2 SIPA1L1 TTLL4 SAR1B PLEKHA5 ATP11A	3.48e-04	536	85	7	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	MEAF6 NDUFAF2 SIPA1L1 TTLL4 SAR1B PLEKHA5 ATP11A	3.55e-04	538	85	7	10512203
Pubmed	New molecular components supporting ryanodine receptor-mediated Ca(2+) release: roles of junctophilin and TRIC channel in embryonic cardiomyocytes.	RYR2 RYR3	3.83e-04	12	85	2	19095005
Pubmed	Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.	ABRA MTMR6 GARNL3 MANEA ODAD4 USP37 CA10 SAR1A	5.03e-04	750	85	8	11230166
Pubmed	The protein kinase KIS impacts gene expression during development and fear conditioning in adult mice.	GLRB GLRA3	5.27e-04	14	85	2	22937132
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	ZC3H7A RINT1 ZNF789 ARHGAP12 NOL6 KRT20 ATP11A KAT2A SPAG17 RYR2 SLC6A14	7.66e-04	1442	85	11	35575683
Pubmed	Human variation in alcohol response is influenced by variation in neuronal signaling genes.	GLRB SIX3 RYR3 PLCE1	8.38e-04	171	85	4	20201926
Pubmed	Genome-wide association study identifies genetic risk underlying primary rhegmatogenous retinal detachment.	GOLPH3L CTSS	8.80e-04	18	85	2	23585552
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	CCDC59 RASA2 DYNC2H1 CSNK2A2 NOL6 SAR1A RYR2	9.70e-04	638	85	7	31182584
Pubmed	Association studies of 23 positional/functional candidate genes on chromosome 10 in late-onset Alzheimer's disease.	SAR1A PLCE1	9.83e-04	19	85	2	17373700
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	ZC3H7A NRDE2 CCDC59 TENT4B MARS1 CSNK2A2 SIPA1L1 NOL6 GPRC5C KAT2A DUSP11	1.04e-03	1497	85	11	31527615
Pubmed	Genome-wide RNAi screen identifies the Parkinson disease GWAS risk locus SREBF1 as a regulator of mitophagy.	CSNK2A2 KAT2A	1.09e-03	20	85	2	24912190
Pubmed	RUNX1 maintains the identity of the fetal ovary through an interplay with FOXL2.	PLA2R1 RYR2	1.20e-03	21	85	2	31712577
Pubmed	PRDM16 determines specification of ventricular cardiomyocytes by suppressing alternative cell fates.	CACNA2D2 RYR3	1.20e-03	21	85	2	39304345
Pubmed	Interaction proteomics of canonical Caspr2 (CNTNAP2) reveals the presence of two Caspr2 isoforms with overlapping interactomes.	LGI3 LGI1	1.20e-03	21	85	2	25707359
Pubmed	Large-scale screen for genes involved in gonad development.	PTOV1 NIPSNAP1 PLEKHA5	1.25e-03	86	85	3	11044607
Pubmed	Stage-dependent and locus-specific role of histone demethylase Jumonji D3 (JMJD3) in the embryonic stages of lung development.	KIRREL3 MARCHF4	1.32e-03	22	85	2	25079229
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	NRDE2 MTMR6 RASA2 MARS1 CSNK2A2 POLG SIPA1L1 TTLL4 ATP11A	1.33e-03	1084	85	9	11544199
Pubmed	The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1.	CSNK2A2 TDRD6 RYR2 DUSP11	1.41e-03	197	85	4	20811636
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	H1-10 TENT4B CSNK2A2 NOL6 WDR46	1.68e-03	349	85	5	25665578
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	ZC3H7A H1-10 ALKBH1 RASA2 MARS1 NOL6 NIPSNAP1 WDR46 PLEKHA5 NCCRP1	1.70e-03	1353	85	10	29467282
Pubmed	Identification of 15 loci influencing height in a Korean population.	KRT20 SPAG17	1.99e-03	27	85	2	19893584
Pubmed	Intestinal NCoR1, a regulator of epithelial cell maturation, controls neonatal hyperbilirubinemia.	KRT20 NOX4	1.99e-03	27	85	2	28167773
Cytoband	Ensembl 112 genes in cytogenetic band chr2q35	GLB1L TTLL4 USP37 MARCHF4	1.01e-04	129	85	4	chr2q35
Cytoband	2q35	GLB1L USP37 MARCHF4	4.38e-04	79	85	3	2q35
GeneFamily	Ryanodine receptors\|Protein phosphatase 1 regulatory subunits	RYR2 RYR3	3.46e-05	3	62	2	287
GeneFamily	Glycine receptors	GLRB GLRA3	1.15e-04	5	62	2	868
GeneFamily	Myotubularins\|Phosphoinositide phosphatases	MTMR6 MTM1	1.18e-03	15	62	2	903
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ABRA ANGPT2 TTLL4 ARHGAP12 MARCHF4 HEPH	1.15e-06	177	85	6	8abdf1d970b2f15e17e185f3e612dd5065c88757
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M LOXHD1 SPAG17 RYR2 RYR3 PLCE1	1.44e-06	184	85	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M LOXHD1 SPAG17 RYR2 RYR3 PLCE1	1.44e-06	184	85	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	A2M LOXHD1 SPAG17 RYR2 RYR3 PLCE1	1.44e-06	184	85	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	human_hepatoblastoma-Endothelial_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	LOXHD1 ANGPT2 RBMS3 ESAM NOX4 PREX2	1.85e-06	192	85	6	e09f609fed033a25baacaf4a07bbbae1076da366
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M ADAMTS2 RBMS3 COL27A1 PREX2 RYR2	1.90e-06	193	85	6	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M ANGPT2 ESAM GPRC5C RASGRP2 PLCE1	1.96e-06	194	85	6	3b9ada901dfe7a5cc4861a883d3268c53b11e5b6
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M PLA2R1 LOXHD1 ADAMTS2 RBMS3 COL27A1	2.02e-06	195	85	6	44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9
ToppCell	356C-Epithelial_cells-Epithelial-A_(AT2)\|356C / Donor, Lineage, Cell class and subclass (all cells)	CACNA2D2 LGI3 ESAM GPRC5C ATP11A SLC6A14	2.08e-06	196	85	6	93a5d9b8bcff7d07596ef1f4f2b74f043835fc69
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M ANGPT2 ESAM GPRC5C RASGRP2 PLCE1	2.08e-06	196	85	6	624f700daea48d9bad4cc554f4776bd809ae1e54
ToppCell	356C-Epithelial_cells-Epithelial-A_(AT2)-\|356C / Donor, Lineage, Cell class and subclass (all cells)	CACNA2D2 LGI3 ESAM GPRC5C ATP11A SLC6A14	2.08e-06	196	85	6	4715f19f844e7244fc4bc446cba7c8088c600fc3
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-A\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	A2M MMP25 ANGPT2 ESAM NOX4 PREX2	2.21e-06	198	85	6	72e8b9cccb7b0a2ea9d415218fff4fa2f09728f4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	A2M MMP25 ANGPT2 ESAM NOX4 PREX2	2.27e-06	199	85	6	9c40b3ee39860e9d8edafd007daec11abdd95435
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MMP25 ANGPT2 RBMS3 ESAM NOX4 PREX2	2.27e-06	199	85	6	d95d78b2ebc9a20532466e4d4be579b4faf6776f
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Scavenging_endothelial-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MMP25 ANGPT2 RBMS3 ESAM NOX4 PREX2	2.27e-06	199	85	6	cdcfca94baba66e213cc3ffb0cfb4c75d6ab44ec
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	A2M MMP25 ANGPT2 ESAM NOX4 PREX2	2.27e-06	199	85	6	72b34bce8157abe389e95cd3ed8ba578dce0cbf6
ToppCell	Tracheal-10x3prime_v2-Stromal-Pericyte\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	A2M ESAM ADCY5 PREX2 RYR2 PLCE1	2.34e-06	200	85	6	600d56257b1b0cda8ed2fd0db92c6551711f7d6d
ToppCell	droplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS2 GLB1L COL27A1 TLR5 CTSS	1.48e-05	162	85	5	71d7849108a1b59beff40e46000172c45a2f5439
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	A2M PLA2R1 ADAMTS2 FRRS1L RYR3	1.81e-05	169	85	5	16c52a0f6d96ecc1832922fce9b39691849f0d73
ToppCell	droplet-Lung-18m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLEKHA5 BARX2 CLNK NCCRP1 PLCE1	1.87e-05	170	85	5	bf589c4297ccc90e5f51e3d0fcc229548af4fcef
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Enterocyte_(Proximal)\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT20 ATP11A CTSS HEPH SLC6A14	1.92e-05	171	85	5	5d0d6c1ff610a703ae0b834a12823c5ff9012932
ToppCell	droplet-Lung-30m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	PLEKHA5 BARX2 CLNK NCCRP1 PLCE1	2.03e-05	173	85	5	70c0c13febd28b395fb3171ec8d7fbbc6c9d4eb7
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)\|bone_marrow / Manually curated celltypes from each tissue	ZGRF1 TTLL4 GLRA3 PLEKHA5 ZNF440	2.03e-05	173	85	5	67f0f0bf88eab69987b71d96b864ed2b14975adb
ToppCell	Children_(3_yrs)-Mesenchymal-pericyte_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M ADCY5 PREX2 RYR2 PLCE1	2.33e-05	178	85	5	185b44700f06ec58b3c09c80520502166c965fd6
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLA2R1 KIRREL3 CA10 RYR3 PLCE1	2.39e-05	179	85	5	7394e77e665bf16d3733df91bb12907be460ab44
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PLA2R1 ZGRF1 ESAM ATP11A PREX2	2.52e-05	181	85	5	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLA2R1 GLRA3 CA10 RYR3 PLCE1	2.52e-05	181	85	5	5bf7aa43f6e6ecce15c95928b91195544d6928c4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	PLA2R1 GLRA3 CA10 RYR3 PLCE1	2.52e-05	181	85	5	8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9
ToppCell	COVID-19-Fibroblasts-Pericytes\|COVID-19 / group, cell type (main and fine annotations)	RBMS3 ADCY5 PREX2 RYR2 PLCE1	2.80e-05	185	85	5	4905adaeeffd353e089578e5ea614437dbe794e6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	PLA2R1 KIRREL3 CA10 RYR3 PLCE1	2.80e-05	185	85	5	b848b63aff4d9dbb9e66a85876d4c7c6dacd0579
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	H1-10 ADAMTS2 SPAG17 CTSS RYR2	2.87e-05	186	85	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANGPT2 RBMS3 NOX4 GPRC5C ADCY5	2.87e-05	186	85	5	26458ff8cad5577de4306cffa0ca69eb26940e0d
ToppCell	facs-Lung-18m-Mesenchymal-myofibroblast-myofibroblast_cell-pulmonary_interstitial_myofibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANGPT2 RBMS3 NOX4 GPRC5C ADCY5	2.87e-05	186	85	5	a71397efc68d2916ddc373d92cfd07be58033e1c
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	GARNL3 GLB1L TTLL4 TLR5 SIX3	2.95e-05	187	85	5	f5a202d5f8eb57b57d80815ce98774e04c387383
ToppCell	IPF-Epithelial-ATII\|Epithelial / Disease state, Lineage and Cell class	CACNA2D2 LGI3 ESAM ATP11A SLC6A14	3.02e-05	188	85	5	5f5fad2773e421760e67dbace23fd1f847a2e1e0
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ANGPT2 ADCY5 RYR2 PLCE1	3.10e-05	189	85	5	7fbe855bfdb47d35e040b04a80fe4b729a3764e8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ANGPT2 ADCY5 RYR2 PLCE1	3.10e-05	189	85	5	06b35abecd29f902cf251fcc1f6ad33db7ab08a2
ToppCell	AT2_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	CACNA2D2 COL27A1 LGI3 ESAM ATP11A	3.10e-05	189	85	5	2d32f09efa982ae458568f6b1cd06bb5078d42a3
ToppCell	Mesenchymal-pericyte_cell\|World / Lineage, Cell type, age group and donor	ANGPT2 ADCY5 PREX2 RYR2 PLCE1	3.10e-05	189	85	5	d7ed96add29f219183c802895fbff519b627f635
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RBMS3 ADCY5 PREX2 RYR2 PLCE1	3.18e-05	190	85	5	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	CACNA2D2 FRRS1L SIX3 RYR2 LGI1	3.18e-05	190	85	5	6e92c78799f34b31d098854503c796edb0dc7f80
ToppCell	human_hepatoblastoma-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	LOXHD1 ANGPT2 RBMS3 NOX4 PREX2	3.18e-05	190	85	5	8d6ef93d69e96cd6921816d152bea3b0710cf147
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	MTMR6 CACNA2D2 RBMS3 ARHGAP12 PLCE1	3.18e-05	190	85	5	39ab890104b4264c68a968f920f4ccd84f0bc681
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	RBMS3 ADCY5 PREX2 RYR2 PLCE1	3.18e-05	190	85	5	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KIRREL3 GPRC5C BARX2 SIX3 NCCRP1	3.26e-05	191	85	5	e96184aee03175fd9f1da11fa2b89d95ba58b817
ToppCell	Control-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	ANGPT2 ESAM GPRC5C ADCY5 RASGRP2	3.26e-05	191	85	5	2da83c493e60ad0278848957645277d76737a188
ToppCell	COVID-19-Myeloid-DC1\|Myeloid / Condition, Lineage and Cell class	GARNL3 ESAM PLEKHA5 CLNK PREX2	3.26e-05	191	85	5	4be3c6287965fe3a2f109d26f68bdc2fa393f99b
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M LOXHD1 ADAMTS2 RBMS3 COL27A1	3.34e-05	192	85	5	9093a9e94a25682d109a7f6edc256a25a61103a0
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M LOXHD1 ADAMTS2 RBMS3 COL27A1	3.34e-05	192	85	5	9ed5d49621ec1aa01716dc369bba1450b5f015f5
ToppCell	IPF-Stromal-SMC\|Stromal / Disease state, Lineage and Cell class	ANGPT2 ESAM GPRC5C ADCY5 RASGRP2	3.34e-05	192	85	5	9b06c7336624ef21f8e5393725b56038a8028e57
ToppCell	Control-Myeloid-cMonocyte\|Control / Disease state, Lineage and Cell class	TENT4B ADAMTS2 SIPA1L1 FAM157C CTSS	3.34e-05	192	85	5	ad04c9c4bdebf94615cee1904ca48197e62c923b
ToppCell	normal_Lung-Epithelial_cells-AT2\|normal_Lung / Location, Cell class and cell subclass	CACNA2D2 LGI3 GPRC5C ATP11A SLC6A14	3.42e-05	193	85	5	80ad1bdc50ecb8a50362f718248441cae20904a6
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	A2M ADAMTS2 RBMS3 PREX2 RYR2	3.42e-05	193	85	5	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	A2M RBMS3 NOX4 PLEKHA5 RYR2	3.42e-05	193	85	5	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANGPT2 RBMS3 GPRC5C RASGRP2 PLCE1	3.42e-05	193	85	5	7766f495f2f945802ef9a5b994cd00bb64d0dfe3
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.3\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CACNA2D2 DYNC2H1 ATP11A ODAD4 SPAG17	3.42e-05	193	85	5	bdb7401dd9059032f930f2b575f2ef8e504b6594
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|metastatic_Brain / Location, Cell class and cell subclass	A2M ANGPT2 ESAM HEPH PLCE1	3.51e-05	194	85	5	d1889a3e22d5b88461c81ec3ea0e74bb9bf63e60
ToppCell	Control-Myeloid-cMonocyte\|World / Disease state, Lineage and Cell class	TENT4B ADAMTS2 SIPA1L1 FAM157C CTSS	3.51e-05	194	85	5	f852f5258617a66a4fbd56d64c7b47272e7b8b60
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M PLA2R1 LOXHD1 ADAMTS2 RBMS3	3.51e-05	194	85	5	240d122dcb9dd1ab2867503ad85869853adcacae
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M PLA2R1 LOXHD1 ADAMTS2 RBMS3	3.51e-05	194	85	5	ae7df037592f1c20c9d32be15fe6fc3c562ebeb1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ANGPT2 ADCY5 RYR2 PLCE1	3.51e-05	194	85	5	5c3b2b05d1e4f146551fe4c920263d8e6ca34de3
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ANGPT2 ADCY5 RYR2 PLCE1	3.51e-05	194	85	5	ab9cad697f9209d2889bc02b43b502dfeb2ebfef
ToppCell	356C-Epithelial_cells\|356C / Donor, Lineage, Cell class and subclass (all cells)	CACNA2D2 LGI3 GPRC5C ATP11A SLC6A14	3.60e-05	195	85	5	d913d0a6c4797d9a873ddea6f340c3f152da1cf3
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M ANGPT2 ESAM GPRC5C RASGRP2	3.60e-05	195	85	5	815ac5dacd382b11abb32011ed1c0635b0ddc779
ToppCell	(7)_Epithelial-A_(AT2)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	CACNA2D2 LGI3 GPRC5C ATP11A SLC6A14	3.60e-05	195	85	5	c9a6c65ee18d83bf34a4713d306a6e30db1325c2
ToppCell	normal_Lung-Epithelial_cells-AT2\|Epithelial_cells / Location, Cell class and cell subclass	CACNA2D2 LGI3 ESAM ATP11A SLC6A14	3.60e-05	195	85	5	81e13fe337f1d0a83d0deb86a0df797d306cd24d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M LOXHD1 ADAMTS2 RBMS3 HEPH	3.60e-05	195	85	5	cad6563cc51d212554152c727fc2c249c6a07e4d
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M LOXHD1 ADAMTS2 RBMS3 HEPH	3.60e-05	195	85	5	783bfa8110161cbd6def50ce849cae676c39c458
ToppCell	ASK440-Epithelial-Type_2\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	CACNA2D2 LGI3 GPRC5C ATP11A SLC6A14	3.69e-05	196	85	5	754b4202b617165c6994a0b5a9b1e486dccdd44d
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-K_(Pericytes)\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	ANGPT2 ESAM GPRC5C ADCY5 RASGRP2	3.69e-05	196	85	5	541b1fcf509e362f6f48720046cb5378aaf7c591
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	A2M ANGPT2 ESAM RASGRP2 PLCE1	3.69e-05	196	85	5	c16fbd23d9e117831b55ab3da5b08b22dd972432
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M LOXHD1 ADAMTS2 RBMS3 COL27A1	3.69e-05	196	85	5	ba869f7a86f37fd6d84d6ad69baca0e0faaf5887
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M LOXHD1 ADAMTS2 RBMS3 COL27A1	3.69e-05	196	85	5	30ad56d49000e4ddce73b4443b3994564bd1e2d6
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ADAMTS2 RBMS3 PREX2 HEPH	3.69e-05	196	85	5	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ADAMTS2 RBMS3 PREX2 HEPH	3.69e-05	196	85	5	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	COVID-19-lung-Pericytes/_Smooth_Muscle\|COVID-19 / Disease (COVID-19 only), tissue and cell type	A2M ADCY5 PREX2 RYR2 PLCE1	3.69e-05	196	85	5	754a3613340932563cd8424d775e18b93c3a1aaa
ToppCell	10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PLA2R1 ANGPT2 RBMS3 ESAM PLCE1	3.69e-05	196	85	5	12d9028f90c057c6e5cff00301793fa550e86c5a
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MMP25 ANGPT2 ESAM NOX4 PREX2	3.69e-05	196	85	5	ed818de15f84f7f28bd06fd69d7876710da232a0
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MMP25 ANGPT2 ESAM NOX4 PREX2	3.78e-05	197	85	5	62c0a90869431e582bb7bb329e0b0cc59123d3d1
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	A2M PLA2R1 RBMS3 COL27A1 RYR2	3.78e-05	197	85	5	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ADAMTS2 RBMS3 COL27A1 PREX2	3.78e-05	197	85	5	85a8f1d18e0dd1d31341f5131eecd217553bf042
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ADAMTS2 RBMS3 COL27A1 PREX2	3.78e-05	197	85	5	e8e3ba791dfaa0fab35e0329a5e34376f9ee6143
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	A2M ANGPT2 ESAM ADCY5 RASGRP2	3.78e-05	197	85	5	71367bebc23d0e81f60f780d6b0ab3a1783ac014
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	A2M ADAMTS2 RBMS3 COL27A1 PREX2	3.78e-05	197	85	5	9b480f9c799a244bfee64487abd8a1bf07c9a3a2
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MMP25 ANGPT2 ESAM NOX4 PREX2	3.78e-05	197	85	5	16f0eb047df9d702518f82ee99c6e7dc1350b2fb
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Pericytes\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ANGPT2 ESAM GPRC5C RASGRP2 PLCE1	3.78e-05	197	85	5	608328608cef82adc867a449216839622253d486
ToppCell	356C-Fibroblasts-Fibroblast-K_(Pericytes)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	A2M ANGPT2 ESAM ADCY5 RASGRP2	3.78e-05	197	85	5	0f9836554ace3f9d155ebafdd719aa26466ca44e
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M RBMS3 ESAM PREX2 RYR3	3.87e-05	198	85	5	07701c73137947ed4a27e225975329235bbb8734
ToppCell	367C-Epithelial_cells-Epithelial-E_(AT2)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CACNA2D2 LGI3 ESAM ATP11A SLC6A14	3.87e-05	198	85	5	85215015bb86ada0e871c413a4ecdc903a3785ca
ToppCell	Transplant_Alveoli_and_parenchyma-Mesenchymal-Smooth_muscle\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	A2M ANGPT2 ESAM GPRC5C ADCY5	3.87e-05	198	85	5	89986c7756541df364df516329d10775ba0e78a4
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Endothelial\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	A2M MMP25 ANGPT2 ESAM NOX4	3.87e-05	198	85	5	e1fa02184ce93c4f8aa5cf04b70949cd4c425ff0
ToppCell	Adult-Mesenchymal\|Adult / Lineage, Cell type, age group and donor	A2M ADAMTS2 RBMS3 NOX4 RYR2	3.87e-05	198	85	5	26e55b409db2a1637c95fae7c54b0abea1ef550c
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	ADAMTS2 DYNC2H1 COL27A1 RYR2 RYR3	3.87e-05	198	85	5	0c4d2c68a42f8a9e964e2dd28092fe75f5216834
ToppCell	metastatic_Brain-Fibroblasts-Pericytes\|Fibroblasts / Location, Cell class and cell subclass	A2M ANGPT2 ESAM GPRC5C PLCE1	3.87e-05	198	85	5	86a4c8e859ce11a95875f8844963baeb1ba898ec
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FRRS1L GLRB CA10 ADCY5 RYR2	3.87e-05	198	85	5	d1827e3707b929e3a3562989a0c11537d344e164
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	A2M PLA2R1 ADAMTS2 COL27A1 RYR2	3.87e-05	198	85	5	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	A2M RBMS3 ESAM PREX2 RYR3	3.87e-05	198	85	5	fa84bf8533d1b91d2c2bcf06b710670605072b89
ToppCell	367C-Epithelial_cells-Epithelial-E_(AT2)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	CACNA2D2 LGI3 ESAM ATP11A SLC6A14	3.87e-05	198	85	5	38349e42a3f1fb700ff6dfd89c4bf5ff97f1a3e9
ToppCell	Skin-Endothelial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	A2M RBMS3 ESAM CTSS PREX2	3.96e-05	199	85	5	6b3ef5d8f87cdfe5401d05f19339ddfcd9cda476
ToppCell	Skin-Mesangial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	A2M LOXHD1 RBMS3 TTLL4 MARCHF4	3.96e-05	199	85	5	bcb78838a91cc7828680fb413fbacdb091c5fac0
Drug	lead compounds	CSNK2A2 CA10 ADCY5 RYR2 RYR3 PLCE1	1.84e-05	150	83	6	CID000073212
Drug	heptachlorobiphenyl	MARS1 UROD	3.93e-05	3	83	2	CID000050102
Drug	2-hydroxycarbazole	RYR2 RYR3	3.93e-05	3	83	2	CID000093551
Drug	cis-diammineplatinum(II	RYR2 RYR3	3.93e-05	3	83	2	CID000159790
Drug	2-hydroxyheptanoic acid	RYR2 RYR3	3.93e-05	3	83	2	CID002750949
Drug	Ryanodyl 3-(pyridine-3-carboxylate	RYR2 RYR3	3.93e-05	3	83	2	CID005748312
Drug	8N3-cADPR	RYR2 RYR3	3.93e-05	3	83	2	CID000127713
Drug	aminodantrolene	RYR2 RYR3	3.93e-05	3	83	2	CID009570289
Drug	baclofen	CACNA2D2 GLRB GLRA3 ADCY5 RYR2 RYR3	7.12e-05	191	83	6	CID000002284
Drug	iso-THAZ	GLRB GLRA3	7.84e-05	4	83	2	CID003047783
Drug	protostrychnine	GLRB GLRA3	7.84e-05	4	83	2	CID005320746
Drug	7-nitroindoline	GLRB GLRA3	7.84e-05	4	83	2	CID013566747
Drug	2-(phosphonomethyl)phenylalanine	GLRB GLRA3	7.84e-05	4	83	2	CID000383689
Drug	SC-49648	GLRB GLRA3	7.84e-05	4	83	2	CID000195696
Drug	PCB74	RYR2 RYR3	7.84e-05	4	83	2	CID000036218
Drug	akuammiline	GLRB GLRA3	7.84e-05	4	83	2	CID005367018
Drug	148504-47-6	RYR2 RYR3	7.84e-05	4	83	2	CID006444275
Drug	NSC381080	GLRB GLRA3	7.84e-05	4	83	2	CID000165497
Drug	N-methyl-THIP	GLRB GLRA3	7.84e-05	4	83	2	CID000134373
Drug	SC-48981	GLRB GLRA3	7.84e-05	4	83	2	CID000126573
Drug	SC 38249	RYR2 RYR3	7.84e-05	4	83	2	CID000134834
Drug	SC-50132	GLRB GLRA3	7.84e-05	4	83	2	CID000195719
Drug	AC1L1U7A	RYR2 RYR3	7.84e-05	4	83	2	CID000035682
Drug	SR 42641	GLRB GLRA3	7.84e-05	4	83	2	CID000129049
Drug	gluconate	MMP25 ABRA COL27A1 GLRB UROD ADCY5 LGI1	8.61e-05	287	83	7	CID000000604
Drug	aldosterone	MMP25 ABRA CACNA2D2 COL27A1 NOX4 SAR1A RYR2 RYR3	1.00e-04	397	83	8	CID000005839
Drug	azetidine-3-carboxylic acid	GLRB GLRA3	1.30e-04	5	83	2	CID000093192
Drug	Lindane	GLRB GLRA3	1.30e-04	5	83	2	DB00431
Drug	Cao C	GLRB GLRA3	1.30e-04	5	83	2	CID000166617
Drug	oxanilide	GLRB GLRA3	1.30e-04	5	83	2	CID000069288
Drug	iso-THAO	GLRB GLRA3	1.30e-04	5	83	2	CID000127199
Drug	ALX1393	GLRB GLRA3	1.30e-04	5	83	2	CID016078939
Drug	pleiocarpamine	GLRB GLRA3	1.30e-04	5	83	2	CID000558637
Drug	mafoprazine	GLRB GLRA3	1.30e-04	5	83	2	CID000071241
Drug	gevotroline	GLRB GLRA3	1.30e-04	5	83	2	CID000060546
Drug	halothane	CACNA2D2 GLRB GLRA3 ADCY5 RYR2 RYR3 PLCE1	1.50e-04	314	83	7	CID000003562
Drug	THAZ	GLRB GLRA3	1.95e-04	6	83	2	CID000171289
Drug	mV GABA	GLRB GLRA3	1.95e-04	6	83	2	CID000128435
Drug	caged glycine	GLRB GLRA3	1.95e-04	6	83	2	CID000192642
Drug	brometone	GLRB GLRA3	1.95e-04	6	83	2	CID000006424
Drug	MBED	RYR2 RYR3	1.95e-04	6	83	2	CID000129958
Drug	minaxolone	GLRB GLRA3	1.95e-04	6	83	2	CID000071960
Drug	talcum powder	ABRA MARS1	1.95e-04	6	83	2	CID000517272
Drug	chloro-m-cresol	RYR2 RYR3	1.95e-04	6	83	2	CID000012008
Drug	thiomuscimol	GLRB GLRA3	1.95e-04	6	83	2	CID000005448
Drug	AC1O528X	RYR2 RYR3	1.95e-04	6	83	2	CID006475857
Drug	NSC114784	RYR2 RYR3	1.95e-04	6	83	2	CID000419425
Drug	thio-THIP	GLRB GLRA3	1.95e-04	6	83	2	CID000656720
Drug	AC1L90PQ	GLRB GLRA3	1.95e-04	6	83	2	CID000436036
Disease	congenital myopathy 1A (implicated_via_orthology)	RYR2 RYR3	2.40e-05	3	84	2	DOID:3529 (implicated_via_orthology)
Disease	Benign Hereditary Chorea	CACNA2D2 ADCY5	2.40e-05	3	84	2	C0393584
Disease	malignant hyperthermia (implicated_via_orthology)	RYR2 RYR3	2.40e-05	3	84	2	DOID:8545 (implicated_via_orthology)
Disease	uremia (implicated_via_orthology)	ANGPT2 AGL	4.79e-05	4	84	2	DOID:4676 (implicated_via_orthology)
Disease	centronuclear myopathy (implicated_via_orthology)	MTMR6 MTM1	1.67e-04	7	84	2	DOID:14717 (implicated_via_orthology)
Disease	dental caries	ABRA ANGPT2 ADAMTS2 RBMS3 ZGRF1	1.99e-04	187	84	5	EFO_0003819
Disease	centronuclear myopathy X-linked (implicated_via_orthology)	MTMR6 MTM1	2.85e-04	9	84	2	DOID:0111225 (implicated_via_orthology)
Disease	squamous cell carcinoma	NOX4 ATP11A CTSS	9.35e-04	67	84	3	EFO_0000707
Disease	wellbeing measurement, alcohol consumption measurement	MMP25 RBMS3 PREX2	1.25e-03	74	84	3	EFO_0007869, EFO_0007878
Disease	pulmonary hypertension (biomarker_via_orthology)	ANGPT2 RYR2 RYR3	1.56e-03	80	84	3	DOID:6432 (biomarker_via_orthology)
Disease	platelet reactivity measurement, response to clopidogrel	PLEKHA5 PLCE1	1.95e-03	23	84	2	EFO_0004985, GO_1903493
Disease	basal cell carcinoma	FAM157C NOX4 ATP11A CTSS	2.11e-03	189	84	4	EFO_0004193
Disease	Charcot-Marie-Tooth disease (implicated_via_orthology)	MTMR6 MTM1	2.12e-03	24	84	2	DOID:10595 (implicated_via_orthology)
Disease	HVA measurement	GARNL3 RBMS3	2.49e-03	26	84	2	EFO_0005131
Disease	Lewy body dementia, Lewy body dementia measurement	ABRA GARNL3	2.49e-03	26	84	2	EFO_0006792, EFO_0006799
Disease	migraine disorder, pulse pressure measurement	DYNC2H1 PLCE1	2.49e-03	26	84	2	EFO_0005763, MONDO_0005277

Protein segments in the cluster

Peptide	Gene	Start	Entry
QSPVNFYRWKIEQLQ	CATSPERG	131	Q6ZRH7
RVQDVFEKYNWPNRT	CACNA2D2	406	Q9NY47
NAYRAGLQPVSKWQA	ALKBH1	76	Q13686
PQRQNTNKFNGIKWY	ANGPT2	461	O15123
ARKPQYDIWGNTVNV	ADCY5	1191	O95622
NVCRWAYLQQKPDTG	ADAMTS2	341	O95450
YIQDPKGNRIAQWQS	A2M	166	P01023
KRAYSRKPWDNQQQT	MROH7	1166	Q68CQ1
QNQSKYTQNGRPWPR	RBMS3	231	Q6XE24
QAWYLLQPRDNGNKS	RASA2	286	Q15283
YRVNIFLRQKWNDPR	GLRA3	91	O75311
NYWKLETPAQFRQRS	KAT2A	266	Q92830
TPWKRRNYNQGVVGL	TENT4B	106	Q8NDF8
QAKRWLYQRPQASHQ	UROD	176	P06132
SWPQNGKTYLVRGRQ	MMP25	421	Q9NPA2
TYKWKRQVTQRNPVG	RASGRP2	126	Q7LDG7
SYNPKQNDSERLQGW	MTMR6	111	Q9Y217
KVPWFDQQNGRTYLK	H1-10	76	Q92522
RIPYWRTDNNKNLAQ	LIPJ	31	Q5W064
RQGKQYTFPANRWLD	LOXHD1	776	Q8IVV2
FRGWYIRTEKLQQNQ	NCCRP1	136	Q6ZVX7
NRQQQRKSQLFWGLP	C9orf131	186	Q5VYM1
GNQVLWRSYVQIQNK	NRDE2	996	Q9H7Z3
KNNVRSAWYRGQSPA	NOL6	271	Q9H6R4
PVNQNWERYLAEAQG	POLG	436	P54098
KPSEDIYKNWRRQQQ	FAM157C	61	P0CG43
YRVNIFLRQKWNDPR	GLRB	101	P48167
QIKQWYETNAPRAGR	KRT20	101	P35900
RPWNTQNTRNRINGK	MANEA	366	Q5SRI9
NKFWQENRPDYVNIQ	NOX4	481	Q9NPH5
WELPKYNASSQQQRE	ARHGAP12	386	Q8IWW6
YVNQGEILRTEQWPR	PTOV1	286	Q86YD1
RQKYWNKLQTLRQQP	PANK4	481	Q9NVE7
KDGKNSQVFRNPYVW	GPRC5C	426	Q9NQ84
IKSWLRNQPAEYRNN	DYNC2H1	2126	Q8NCM8
NYIEDLQNGPIRKNW	DUSP11	241	O75319
YNVGQWAKEIQRNPA	FRRS1L	176	Q9P0K9
GLTQLQVKTWYQNRR	BARX2	171	Q9UMQ3
FNLGRYWTKQGPQQT	GLB1L	571	Q6UWU2
STPLQQWRQGEYKCV	IGHD	71	P01880
TWNPFKLQYQLRNVR	GOLPH3L	146	Q9H4A5
PAKQAVRFRAWNGQI	COL27A1	1781	Q8IZC6
VPSWGNQDDYQLVRK	CSNK2A2	31	P19784
SPRSKPAVQYQWDRQ	ESAM	176	Q96AP7
PSVYRIFKRWQAVNQ	MARCHF4	296	Q9P2E8
NIIRGWDRYLTNQKN	MEAF6	56	Q9HAF1
NPAVTQYRWAKRGQI	KIRREL3	276	Q8IZU9
RVPSQWQRNITYKSN	CTSS	96	P25774
WQRNITYKSNPNRIL	CTSS	101	P25774
PNNRAQKLQYRVNEW	CA10	311	Q9NS85
WTYGIQQDVKNRRNP	RYR2	1016	Q92736
NNQRVPQYRAILWRK	GARNL3	131	Q5VVW2
GNNWARAIKYRQENQ	NIPSNAP1	201	Q9BPW8
VRANKVNWQSYLQGQ	ATP6V1H	26	Q9UI12
DNLWYRAVIKEQQPN	TDRD6	1366	O60522
PDQRQQWLRKQYVSL	PLCE1	1016	Q9P212
SNFWRQQKPIYARER	ODAD4	236	Q96NG3
QWNYAPKGRNVITNQ	HEPH	36	Q9BQS7
PFRNNNKWQRNASKG	SIPA1L1	1061	O43166
TPTQVGNWFKNRRQR	SIX3	246	O95343
QARRVWKNYLPAING	SAR1A	81	Q9NR31
GYRNKNVRQKTWRPN	CCDC59	26	Q9P031
ERQFWIGFNKRNPLN	PLA2R1	731	Q13018
WDNPARFAKQIRQQY	SPAG17	636	Q6Q759
QQKYSPVGNLKGRWQ	ABRA	236	Q8N0Z2
KNRSWPRINSATGQY	CLNK	26	Q7Z7G1
EPWYNQKTESERQRN	ATP11A	326	P98196
RWKDQNIEYEHQNPR	ZNF440	46	Q8IYI8
NYYIRWNPRIKQQQP	MTM1	536	Q13496
FRGNRQTNVLSKPEW	RINT1	321	Q6NUQ1
QGWTYGIQQDLKNKR	RYR3	1001	Q15413
PQYKNWRGQTIREKR	NDUFAF2	36	Q8N183
RRPTKQDSIQWVYNS	PREX2	746	Q70Z35
LESNPYRSRKQRQEW	WDR46	486	O15213
QESKRYWQNLEANVP	ZC3H7A	676	Q8IWR0
LRCNQDYTGWNKPRV	USP37	316	Q86T82
VETAREGKQYWNPRN	ZGRF1	801	Q86YA3
IRGFVQKQQYLRWPE	TLR5	806	O60602
WQQRQFYNKQSTLPR	PLEKHA5	506	Q9HAU0
QARRVWKNYLPAING	SAR1B	81	Q9Y6B6
QLPSEQYWNKVALQR	SLC6A14	211	Q9UN76
QPRYFNILTTQWEQK	TTLL4	1041	Q14679
NQYIQVNEPWKRIKG	MARS1	716	P56192
IQDQNAQTRWKQGRY	ZNF789	161	Q5FWF6
SRPNRKYTWNDVGQL	AGL	186	P35573
QRPVIYQWNKATQLF	LGI1	406	O95970
SQAPVIYQWSRTQKQ	LGI3	396	Q8N145